Novo CEO pressed by Senate to chop costs of weight problems, diabetes drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporation would look at new talks with insurers about the listing prices of Wegovy and copyright when they pledge to keep the medicines on their own formularies. Before this summer https://ricardoecdeh.fare-blog.com/30770507/new-step-by-step-map-for-healthcare-news